Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer Meeting Abstract

  


Authors: Saltz, L. B.; Lenz, H. J.; Hochster, H.; Wadler, S.; Hoff, P.; Kemeny, N.; Hollywood, E.; Gonen, M.; Wetherbee, S.; Chen, H.
Abstract Title: Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
Meeting Title: 41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 16 Suppl.
Meeting Dates: 2005 May 13-17
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-06-01
Start Page: 248S
Language: English
ACCESSION: WOS:000230326601401
PROVIDER: wos
DOI: 10.1200/jco.2005.23.16_suppl.3508
Notes: --- - Meeting Abstract: 3508 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - "1" - "Source: Wos"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
MSK Authors
  1. Leonard B Saltz
    761 Saltz
  2. Mithat Gonen
    969 Gonen
  3. Ellen M Hollywood
    41 Hollywood
  4. Nancy Kemeny
    534 Kemeny
Related MSK Work